Report Thumbnail
Product Code LP0913610527SW
Published Date 2026/1/22
English110 PagesGlobal

Global Trypsin/EDTA Digestion Solution Market Growth 2026-2032 ‐ Pharmaceutical / LifeSciense Market


Report Thumbnail
Product Code LP0913610527SW◆An updated version may be available. We will check for you.
Published Date 2026/1/22
English 110 PagesGlobal

Global Trypsin/EDTA Digestion Solution Market Growth 2026-2032 ‐ Pharmaceutical / LifeSciense Market



Abstract

This report provides a comprehensive analysis of the global Trypsin/EDTA Digestion Solution market, which is vital for cell culture and tissue dissociation applications. The study examines market dynamics, including key drivers and trends across various product types and applications such as cell biology and medical research. Covering major regions including the Americas, APAC, and Europe, the research evaluates competitive landscapes and strategic activities of leading players like Thermo Fisher Scientific and Merck. It offers detailed forecasts and segmentation to identify emerging growth opportunities through 2032.

Related Questions

US$ 114 million in 2025 and US$ 176 million in 2032

6.5% (2026 to 2032)

Thermo Fisher Scientific, Promega Corporation, Takara Bio, Merck, Worthington Biochemical Corporation, Bio-Rad Laboratories, AMRESCO, GenScript, Intl Kang, Beyotime, TransGen Biotech, Sangon, Proteintech, Solarbio, NCM Biotech


Summary

Market Overview

The global Trypsin/EDTA Digestion Solution market is predicted to grow from US$ 114 million in 2025 to US$ 176 million in 2032, representing an expected compound annual growth rate (CAGR) of 6.5% from 2026 to 2032.

Product Definition

Trypsin/EDTA Digestion Solution is a mixture consisting of the enzyme trypsin and the chelating agent ethylenediaminetetraacetic acid (EDTA). It is used primarily in cell culture and tissue dissociation applications. This solution facilitates the detachment of adherent cells from culture surfaces or the dissociation of tissue into single-cell suspensions.

Regional Market Analysis

  • United States: The market for Trypsin/EDTA Digestion Solution in the United States is estimated to experience growth from 2025 through 2032.
  • China: The market for Trypsin/EDTA Digestion Solution in China is estimated to experience growth from 2025 through 2032.
  • Europe: The market for Trypsin/EDTA Digestion Solution in Europe is estimated to experience growth from 2025 through 2032.

Market Segmentation

By Type

  • 0.1%
  • 0.25%
  • 1%

By Application

  • Cell Biology
  • Medical

By Region

  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

Competitive Landscape

Key Players

The following companies have been profiled based on primary expert input and analysis of company coverage, product portfolios, and market penetration:

  • Thermo Fisher Scientific
  • Promega Corporation
  • Takara Bio
  • Merck
  • Worthington Biochemical Corporation
  • Bio-Rad Laboratories
  • AMRESCO
  • GenScript
  • Intl Kang
  • Beyotime
  • TransGen Biotech
  • Sangon
  • Proteintech
  • Solarbio
  • NCM Biotech

Market Share and Competition

  • Global key players include Thermo Fisher Scientific, Promega Corporation, Takara Bio, Merck, and Worthington Biochemical Corporation, among others.
  • In terms of revenue, the global two largest companies occupied a significant share of the market in 2025.
  • This report analyzes the strategies of leading global companies, focusing on their Trypsin/EDTA Digestion Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints to understand their unique positions in an accelerating global market.

About the Report

LP Information, Inc. (LPI)'s newest research report, the “Trypsin/EDTA Digestion Solution Industry Forecast,” reviews total world Trypsin/EDTA Digestion Solution sales in 2025 and looks at past sales. It provides a comprehensive analysis by region and market sector of projected Trypsin/EDTA Digestion Solution sales for 2026 through 2032.

With sales broken down by region, market sector, and sub-sector, the report provides a detailed analysis in US$ millions of the world Trypsin/EDTA Digestion Solution industry. This Insight Report highlights key trends related to:

  • Product segmentation
  • Company formation
  • Revenue and market share
  • Latest developments
  • M&A activity

The report evaluates key market trends, drivers, and affecting factors shaping the global outlook and breaks down the forecast by Type, Application, geography, and market size to highlight emerging pockets of opportunity. The study utilizes a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs to offer a nuanced view of the current state and future trajectory of the industry.

Key Questions Addressed

  • What is the 10-year outlook for the global Trypsin/EDTA Digestion Solution market?
  • What factors are driving Trypsin/EDTA Digestion Solution market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Trypsin/EDTA Digestion Solution market opportunities vary by end market size?
  • How does Trypsin/EDTA Digestion Solution break out by Type and by Application?

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Trypsin/EDTA Digestion Solution Annual Sales 2021-2032
      • 2.1.2 World Current & Future Analysis for Trypsin/EDTA Digestion Solution by Geographic Region, 2021, 2025 & 2032
      • 2.1.3 World Current & Future Analysis for Trypsin/EDTA Digestion Solution by Country/Region, 2021, 2025 & 2032
    • 2.2 Trypsin/EDTA Digestion Solution Segment by Type
      • 2.2.1 0.1%
      • 2.2.2 0.25%
      • 2.2.3 1%
      • 2.2.4 Trypsin/EDTA Digestion Solution Sales by Type
        • 2.2.4.1 Global Trypsin/EDTA Digestion Solution Sales Market Share by Type (2021-2026)
        • 2.2.4.2 Global Trypsin/EDTA Digestion Solution Revenue and Market Share by Type (2021-2026)
        • 2.2.4.3 Global Trypsin/EDTA Digestion Solution Sale Price by Type (2021-2026)
    • 2.3 Trypsin/EDTA Digestion Solution Segment by Application
      • 2.3.1 Cell Biology
      • 2.3.2 Medical
      • 2.3.3 Trypsin/EDTA Digestion Solution Sales by Application
        • 2.3.3.1 Global Trypsin/EDTA Digestion Solution Sale Market Share by Application (2021-2026)
        • 2.3.3.2 Global Trypsin/EDTA Digestion Solution Revenue and Market Share by Application (2021-2026)
        • 2.3.3.3 Global Trypsin/EDTA Digestion Solution Sale Price by Application (2021-2026)
  • 3 Global by Company

    • 3.1 Global Trypsin/EDTA Digestion Solution Breakdown Data by Company
      • 3.1.1 Global Trypsin/EDTA Digestion Solution Annual Sales by Company (2021-2026)
      • 3.1.2 Global Trypsin/EDTA Digestion Solution Sales Market Share by Company (2021-2026)
    • 3.2 Global Trypsin/EDTA Digestion Solution Annual Revenue by Company (2021-2026)
      • 3.2.1 Global Trypsin/EDTA Digestion Solution Revenue by Company (2021-2026)
      • 3.2.2 Global Trypsin/EDTA Digestion Solution Revenue Market Share by Company (2021-2026)
    • 3.3 Global Trypsin/EDTA Digestion Solution Sale Price by Company
    • 3.4 Key Manufacturers Trypsin/EDTA Digestion Solution Producing Area Distribution, Sales Area, Product Type
      • 3.4.1 Key Manufacturers Trypsin/EDTA Digestion Solution Product Location Distribution
      • 3.4.2 Players Trypsin/EDTA Digestion Solution Products Offered
    • 3.5 Market Concentration Rate Analysis
      • 3.5.1 Competition Landscape Analysis
      • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
    • 3.6 New Products and Potential Entrants
    • 3.7 Market M&A Activity & Strategy
  • 4 World Historic Review for Trypsin/EDTA Digestion Solution by Geographic Region

    • 4.1 World Historic Trypsin/EDTA Digestion Solution Market Size by Geographic Region (2021-2026)
      • 4.1.1 Global Trypsin/EDTA Digestion Solution Annual Sales by Geographic Region (2021-2026)
      • 4.1.2 Global Trypsin/EDTA Digestion Solution Annual Revenue by Geographic Region (2021-2026)
    • 4.2 World Historic Trypsin/EDTA Digestion Solution Market Size by Country/Region (2021-2026)
      • 4.2.1 Global Trypsin/EDTA Digestion Solution Annual Sales by Country/Region (2021-2026)
      • 4.2.2 Global Trypsin/EDTA Digestion Solution Annual Revenue by Country/Region (2021-2026)
    • 4.3 Americas Trypsin/EDTA Digestion Solution Sales Growth
    • 4.4 APAC Trypsin/EDTA Digestion Solution Sales Growth
    • 4.5 Europe Trypsin/EDTA Digestion Solution Sales Growth
    • 4.6 Middle East & Africa Trypsin/EDTA Digestion Solution Sales Growth
  • 5 Americas

    • 5.1 Americas Trypsin/EDTA Digestion Solution Sales by Country
      • 5.1.1 Americas Trypsin/EDTA Digestion Solution Sales by Country (2021-2026)
      • 5.1.2 Americas Trypsin/EDTA Digestion Solution Revenue by Country (2021-2026)
    • 5.2 Americas Trypsin/EDTA Digestion Solution Sales by Type (2021-2026)
    • 5.3 Americas Trypsin/EDTA Digestion Solution Sales by Application (2021-2026)
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Trypsin/EDTA Digestion Solution Sales by Region
      • 6.1.1 APAC Trypsin/EDTA Digestion Solution Sales by Region (2021-2026)
      • 6.1.2 APAC Trypsin/EDTA Digestion Solution Revenue by Region (2021-2026)
    • 6.2 APAC Trypsin/EDTA Digestion Solution Sales by Type (2021-2026)
    • 6.3 APAC Trypsin/EDTA Digestion Solution Sales by Application (2021-2026)
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 China Taiwan
  • 7 Europe

    • 7.1 Europe Trypsin/EDTA Digestion Solution by Country
      • 7.1.1 Europe Trypsin/EDTA Digestion Solution Sales by Country (2021-2026)
      • 7.1.2 Europe Trypsin/EDTA Digestion Solution Revenue by Country (2021-2026)
    • 7.2 Europe Trypsin/EDTA Digestion Solution Sales by Type (2021-2026)
    • 7.3 Europe Trypsin/EDTA Digestion Solution Sales by Application (2021-2026)
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Trypsin/EDTA Digestion Solution by Country
      • 8.1.1 Middle East & Africa Trypsin/EDTA Digestion Solution Sales by Country (2021-2026)
      • 8.1.2 Middle East & Africa Trypsin/EDTA Digestion Solution Revenue by Country (2021-2026)
    • 8.2 Middle East & Africa Trypsin/EDTA Digestion Solution Sales by Type (2021-2026)
    • 8.3 Middle East & Africa Trypsin/EDTA Digestion Solution Sales by Application (2021-2026)
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis

    • 10.1 Raw Material and Suppliers
    • 10.2 Manufacturing Cost Structure Analysis of Trypsin/EDTA Digestion Solution
    • 10.3 Manufacturing Process Analysis of Trypsin/EDTA Digestion Solution
    • 10.4 Industry Chain Structure of Trypsin/EDTA Digestion Solution
  • 11 Marketing, Distributors and Customer

    • 11.1 Sales Channel
      • 11.1.1 Direct Channels
      • 11.1.2 Indirect Channels
    • 11.2 Trypsin/EDTA Digestion Solution Distributors
    • 11.3 Trypsin/EDTA Digestion Solution Customer
  • 12 World Forecast Review for Trypsin/EDTA Digestion Solution by Geographic Region

    • 12.1 Global Trypsin/EDTA Digestion Solution Market Size Forecast by Region
      • 12.1.1 Global Trypsin/EDTA Digestion Solution Forecast by Region (2027-2032)
      • 12.1.2 Global Trypsin/EDTA Digestion Solution Annual Revenue Forecast by Region (2027-2032)
    • 12.2 Americas Forecast by Country (2027-2032)
    • 12.3 APAC Forecast by Region (2027-2032)
    • 12.4 Europe Forecast by Country (2027-2032)
    • 12.5 Middle East & Africa Forecast by Country (2027-2032)
    • 12.6 Global Trypsin/EDTA Digestion Solution Forecast by Type (2027-2032)
    • 12.7 Global Trypsin/EDTA Digestion Solution Forecast by Application (2027-2032)
  • 13 Key Players Analysis

    • 13.1 Thermo Fisher Scientific
      • 13.1.1 Thermo Fisher Scientific Company Information
      • 13.1.2 Thermo Fisher Scientific Trypsin/EDTA Digestion Solution Product Portfolios and Specifications
      • 13.1.3 Thermo Fisher Scientific Trypsin/EDTA Digestion Solution Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.1.4 Thermo Fisher Scientific Main Business Overview
      • 13.1.5 Thermo Fisher Scientific Latest Developments
    • 13.2 Promega Corporation
      • 13.2.1 Promega Corporation Company Information
      • 13.2.2 Promega Corporation Trypsin/EDTA Digestion Solution Product Portfolios and Specifications
      • 13.2.3 Promega Corporation Trypsin/EDTA Digestion Solution Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.2.4 Promega Corporation Main Business Overview
      • 13.2.5 Promega Corporation Latest Developments
    • 13.3 Takara Bio
      • 13.3.1 Takara Bio Company Information
      • 13.3.2 Takara Bio Trypsin/EDTA Digestion Solution Product Portfolios and Specifications
      • 13.3.3 Takara Bio Trypsin/EDTA Digestion Solution Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.3.4 Takara Bio Main Business Overview
      • 13.3.5 Takara Bio Latest Developments
    • 13.4 Merck
      • 13.4.1 Merck Company Information
      • 13.4.2 Merck Trypsin/EDTA Digestion Solution Product Portfolios and Specifications
      • 13.4.3 Merck Trypsin/EDTA Digestion Solution Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.4.4 Merck Main Business Overview
      • 13.4.5 Merck Latest Developments
    • 13.5 Worthington Biochemical Corporation
      • 13.5.1 Worthington Biochemical Corporation Company Information
      • 13.5.2 Worthington Biochemical Corporation Trypsin/EDTA Digestion Solution Product Portfolios and Specifications
      • 13.5.3 Worthington Biochemical Corporation Trypsin/EDTA Digestion Solution Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.5.4 Worthington Biochemical Corporation Main Business Overview
      • 13.5.5 Worthington Biochemical Corporation Latest Developments
    • 13.6 Bio-Rad Laboratories
      • 13.6.1 Bio-Rad Laboratories Company Information
      • 13.6.2 Bio-Rad Laboratories Trypsin/EDTA Digestion Solution Product Portfolios and Specifications
      • 13.6.3 Bio-Rad Laboratories Trypsin/EDTA Digestion Solution Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.6.4 Bio-Rad Laboratories Main Business Overview
      • 13.6.5 Bio-Rad Laboratories Latest Developments
    • 13.7 AMRESCO
      • 13.7.1 AMRESCO Company Information
      • 13.7.2 AMRESCO Trypsin/EDTA Digestion Solution Product Portfolios and Specifications
      • 13.7.3 AMRESCO Trypsin/EDTA Digestion Solution Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.7.4 AMRESCO Main Business Overview
      • 13.7.5 AMRESCO Latest Developments
    • 13.8 GenScript
      • 13.8.1 GenScript Company Information
      • 13.8.2 GenScript Trypsin/EDTA Digestion Solution Product Portfolios and Specifications
      • 13.8.3 GenScript Trypsin/EDTA Digestion Solution Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.8.4 GenScript Main Business Overview
      • 13.8.5 GenScript Latest Developments
    • 13.9 Intl Kang
      • 13.9.1 Intl Kang Company Information
      • 13.9.2 Intl Kang Trypsin/EDTA Digestion Solution Product Portfolios and Specifications
      • 13.9.3 Intl Kang Trypsin/EDTA Digestion Solution Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.9.4 Intl Kang Main Business Overview
      • 13.9.5 Intl Kang Latest Developments
    • 13.10 Beyotime
      • 13.10.1 Beyotime Company Information
      • 13.10.2 Beyotime Trypsin/EDTA Digestion Solution Product Portfolios and Specifications
      • 13.10.3 Beyotime Trypsin/EDTA Digestion Solution Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.10.4 Beyotime Main Business Overview
      • 13.10.5 Beyotime Latest Developments
    • 13.11 TransGen Biotech
      • 13.11.1 TransGen Biotech Company Information
      • 13.11.2 TransGen Biotech Trypsin/EDTA Digestion Solution Product Portfolios and Specifications
      • 13.11.3 TransGen Biotech Trypsin/EDTA Digestion Solution Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.11.4 TransGen Biotech Main Business Overview
      • 13.11.5 TransGen Biotech Latest Developments
    • 13.12 Sangon
      • 13.12.1 Sangon Company Information
      • 13.12.2 Sangon Trypsin/EDTA Digestion Solution Product Portfolios and Specifications
      • 13.12.3 Sangon Trypsin/EDTA Digestion Solution Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.12.4 Sangon Main Business Overview
      • 13.12.5 Sangon Latest Developments
    • 13.13 Proteintech
      • 13.13.1 Proteintech Company Information
      • 13.13.2 Proteintech Trypsin/EDTA Digestion Solution Product Portfolios and Specifications
      • 13.13.3 Proteintech Trypsin/EDTA Digestion Solution Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.13.4 Proteintech Main Business Overview
      • 13.13.5 Proteintech Latest Developments
    • 13.14 Solarbio
      • 13.14.1 Solarbio Company Information
      • 13.14.2 Solarbio Trypsin/EDTA Digestion Solution Product Portfolios and Specifications
      • 13.14.3 Solarbio Trypsin/EDTA Digestion Solution Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.14.4 Solarbio Main Business Overview
      • 13.14.5 Solarbio Latest Developments
    • 13.15 NCM Biotech
      • 13.15.1 NCM Biotech Company Information
      • 13.15.2 NCM Biotech Trypsin/EDTA Digestion Solution Product Portfolios and Specifications
      • 13.15.3 NCM Biotech Trypsin/EDTA Digestion Solution Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.15.4 NCM Biotech Main Business Overview
      • 13.15.5 NCM Biotech Latest Developments
  • 14 Research Findings and Conclusion

USD 7,320 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.